DIVI S LABORATORIES LTD Intrinsic Value

DIVISLAB · Healthcare · Current price ₹9,221.5

Full stock page
DocStoX fair value
₹2,876
low confidence
Current price
₹9,222
Upside to fair value
-68.8%
Verdict
Avoid
Quality score
5.4 / 10
Model it yourself — Intrinsic Value Calculator
Opens pre-filled with DIVI S LABORATORIES LTD's latest numbers.

Is DIVI S LABORATORIES LTD undervalued?

DocStoX estimates the fair value of DIVI S LABORATORIES LTD at ₹2,876 per share, versus the current market price of ₹9,222. That puts the stock about -68.8% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.

How this fair value is calculated

This estimate blends 4 independent methods: Residual income (₹774), Relative P/E (₹3,783), Graham floor (₹1,172), Analyst target (₹8,332). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.

Bear, base and bull scenarios

Our scenarios span ₹774 (bear) to ₹2,876 (base) to ₹8,332 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.

Margin of safety

Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹9,222 versus an intrinsic value of ₹2,876, DIVI S LABORATORIES LTD currently offers -68.8% of negative margin (i.e. a premium).

More on DIVI S LABORATORIES LTD

Fair ValueDCFValuationFinancial RatiosPeers

DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.